Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI

European Radiology

Volumn 14, Issue 10, 2004, Pages 1793-1801

  Kiessling, Fabian ^a   Lichy, Matthias ^a   Grobholz, Rainer ^b   Heilmann, Melanie ^a   Farhan, Nabeel ^a   Michel, Maurice Stephan ^b   Trojan, Lutz ^b   Ederle, Joerg ^a   Abel, Ulrich ^c   Kauczor, Hans Ulrich ^a   Semmler, Wolfhard ^a   Delorme, Stefan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Tumorzentrum   (Germany)

Author keywords

Dynamic contrast enhanced MRI; Microvessel density; Pharmacokinetic model; Prostate neoplasms

Indexed keywords

CD34 ANTIGEN; GADOLINIUM PENTETATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD VESSEL; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; IMAGE ENHANCEMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TIME; TUMOR LOCALIZATION;

AGED; ANTIGENS, CD34; AREA UNDER CURVE; CARCINOMA; COLORING AGENTS; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MODELS, BIOLOGICAL; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 6344255182     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2386-1     Document Type: Article

References (33)

1. Sarma AV, Schottenfeld D (2002) Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001. Semin Urol Oncol 20:3-9
2. Perrotti M, Han KR, Epstein RE, Kennedy EC, Rabbani F, Badani K, Pantuck AJ, Weiss RE, Cummings KB (1999) Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 162:1314-1317
3. Jager GJ, Severens JL, Thornbury JR, de La Rosette JJ, Ruijs SH, Barentsz JO (2000) Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology 215:445-451
4. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H (2000) The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin N Am 38:115-138
5. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY (1991) Prostate cancer: local staging with endorectal surface coil MRI. Radiology 178:797-802
6. Jager GJ, Barentsz JO, de la Rosette JJMCH, Rosenbusch G (1994) Preliminary results of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. Radiology 34:129-133
7. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM (1993) Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391-395
8. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294-2302
9. Brown G, Macvicar DA, Ayton V, Husband JE (1995) The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 50:601-606
10. Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE (2000) Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99-109
11. Barentsz JO, Engelbrecht M, Jager GJ, Witjes JA, de LaRosette J, van Der Sanden BP, Huisman HJ, Heerschap A (1999) Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 10:295-304
12. Preziosi P, Orlacchio A, Giambattista G, Renzi P, Bortolotti L, Fabiano A, Cruciani E, Pasqualetti P (2003) Enhancement pattern of prostate cancer in dynamic MRI. Eur Radiol 13:925-930
13. Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ (1999) Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 9:311-316
14. Huisman HJ, Engelbrecht MR, Barentsz JO (2001) Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13:607-614
15. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:621-628
16. Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G (1999) Multi-compartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumours as monitored by dynamic MR imaging. J Magn Reson Imaging 10:233-241
17. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ (1995) Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 33:506-514
18. Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, van Kaick G (1999) Pathophysiologic basis of contrast enhancement in breast tumours. J Magn Reson Imaging 10:260-266
19. Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A, Brix G, Schaeffer U, Wilkens C, Schoenberg SO, Essig M, Vaupel P, van Kaick G (1997) Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 57:4777-4786
20. Moehler TM, Hawighorst H, Neben K, Egerer G, Hillengass J, Max R, Benner A, Ho AD, van Kaick G, Goldschmidt H (2001) Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer 93:862-868
21. Schlemmer HP, Merkle J, Grobholz R, Jaeger T, Michel MS, Werner A, Rabe A, van Kaick G (2004) Contrast enhanced dynamic MR imaging for the assessment of microvessel density in prostate cancer. Eur Radiol 14:309-317
22. Kiessling F, Lichy M, Grobholz R, Farhan N, Heilmann M, Michel MS, Trojan L, Werner A, Rabe J, Delorme S, Kauczor HU, Schlemmer HP (2003) Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI. Value of two-compartment model. Radiologe 43:474-480
23. True LD (1994) Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists. Am J Clin Pathol 102:572-579
24. Gleason DF, Mellinger GT (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64
25. Grobholz R, Bohrer MH, Siegsmund M, Jünemann K-P, Bleyl U, Woenckhaus M (2000) Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma. Pathol Res Pract 196:277-284
26. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845
27. Abel U, Berger J, Weber E (1984) MARKERTEST - Verfahren and Programme zur statistischen Validierung biologischer Marker. EDV Biol Med 15:117-125
28. Abel U, Berger J (1986) Comparison of resubstitution, data splitting, the bootstrap, and the jackknife as methods for estimating the validity indices of new marker tests. Biometrical J 28:899-908
29. Tofts PS, Brix G, Buckley DL, Evelhoch JL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223-232
30. Kiessling F, Krix M, Heilmann M, Vosseler S, Lichy M, Fink C, Farhan N, Kleinschmidt K, Schad L, Fusenig NE, Delorme S (2003) Comparing dynamic parameters of tumour vascularization in nude mice revealed by MRI and contrast enhanced intermittent power Doppler sonography. Invest Radiol 38:516-524
31. Rouviere O, Raudrant A, Ecochard R, Colin-Pangaud C, Pasquiou C, Bouvier R, Marechal JM, Lyonnet D (2003) Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13:931-942
32. Jager GJ, Ruijter ETG, vd Ka CA et al (1997) Dynamic turbo-FLASH substraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathology. Radiology 203:645-652
33. Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229:248-254